Cargando…
Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638182/ https://www.ncbi.nlm.nih.gov/pubmed/34852817 http://dx.doi.org/10.1186/s13046-021-02183-3 |
| _version_ | 1784608899959095296 |
|---|---|
| author | Li, Weidong Dong, Xuesong He, Changjun Tan, Gang Li, Ziyi Zhai, Bo Feng, Jing Jiang, Xian Liu, Chang Jiang, Hongchi Sun, Xueying |
| author_facet | Li, Weidong Dong, Xuesong He, Changjun Tan, Gang Li, Ziyi Zhai, Bo Feng, Jing Jiang, Xian Liu, Chang Jiang, Hongchi Sun, Xueying |
| author_sort | Li, Weidong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8638182 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86381822021-12-02 Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells Li, Weidong Dong, Xuesong He, Changjun Tan, Gang Li, Ziyi Zhai, Bo Feng, Jing Jiang, Xian Liu, Chang Jiang, Hongchi Sun, Xueying J Exp Clin Cancer Res Correction BioMed Central 2021-12-01 /pmc/articles/PMC8638182/ /pubmed/34852817 http://dx.doi.org/10.1186/s13046-021-02183-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Li, Weidong Dong, Xuesong He, Changjun Tan, Gang Li, Ziyi Zhai, Bo Feng, Jing Jiang, Xian Liu, Chang Jiang, Hongchi Sun, Xueying Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells |
| title | Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells |
| title_full | Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells |
| title_fullStr | Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells |
| title_full_unstemmed | Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells |
| title_short | Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells |
| title_sort | correction to: lncrna snhg1 contributes to sorafenib resistance by activating the akt pathway and is positively regulated by mir-21 in hepatocellular carcinoma cells |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638182/ https://www.ncbi.nlm.nih.gov/pubmed/34852817 http://dx.doi.org/10.1186/s13046-021-02183-3 |
| work_keys_str_mv | AT liweidong correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells AT dongxuesong correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells AT hechangjun correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells AT tangang correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells AT liziyi correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells AT zhaibo correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells AT fengjing correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells AT jiangxian correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells AT liuchang correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells AT jianghongchi correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells AT sunxueying correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells |